Details of the Drug Formulaction

General Information of Drug Formulation (ID: F10682)

• Formulation Name: Irbesartan 150 mg tablet
• Company: Bristol-Myers Squibb Company; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Physicians Total Care

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Irbesartan	(DMTP1DC)	Hypertension	BA00-BA04	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Carmellose sodium	(E00625)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Poloxamer 188	(E00645)	Not Available	Emulsifying agent; Solubilizing agent; Surfactant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent